A Study to Assess the Effects of Cyclosporine on the Pharmacokinetics and Safety of Canagliflozin (JNJ-28431754) in Healthy Volunteers

NCT01718652 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Canagliflozin (JNJ-28431754)
DRUG: Cyclosporine

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.